These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23818456)

  • 1. Adiponectin in coronary heart disease and newly diagnosed impaired glucose tolerance.
    Azizi Ghanbari A; Dörr R; Spitzer S; Stumpf J; Britz A; Amann-Zalan I; Lodwig V; Ulm B; Schnell O; Lohmann T
    Diab Vasc Dis Res; 2013 Sep; 10(5):452-8. PubMed ID: 23818456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma level of adiponectin in coronary heart disease patients combined with abnormal glucose metabolism].
    Xia K; Guo L; Zhao Z; Md Sayed AS; Li F; Yang T
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 37(2):179-84. PubMed ID: 22561436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of abnormal glucose regulation in patients with chronic ischemic heart failure].
    Liu H; Yu JM; Chen F; Pan CY; Li J; Hu DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 May; 35(5):443-6. PubMed ID: 17711687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
    El-Mesallamy HO; Hamdy NM; Salman TM; Mahmoud S
    Minerva Endocrinol; 2011 Sep; 36(3):163-70. PubMed ID: 22019747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma adiponectin and E-selectin concentrations in patients with coronary heart disease and newly diagnosed disturbances of glucose metabolism.
    Kowalska I; Straczkowski M; Nikołajuk A; Kinalska I; Górska M; Prokop J; Bachórzewska-Gajewska H; Musiał W
    Adv Med Sci; 2006; 51():94-7. PubMed ID: 17357284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influencing factors for the plasma concentration of N-terminal brain natriuretic peptide precursor in patients with heart failure due to various heart diseases].
    Wei BQ; Zhang J; Yang YJ; Zhang YH; Huang XH; Yu LT; Zhou Q; Tan HQ; Yang YM; Wang GG; Zhu J
    Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(38):2683-7. PubMed ID: 22321977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].
    Yang CL; Qiu YR; Zhou F; Feng PF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):866-9. PubMed ID: 18504223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Abnormal glucose tolerance and long-term prognosis in patients with acute myocardial infarction].
    David LA; Grosu AA
    Kardiologiia; 2013; 53(9):15-20. PubMed ID: 24090381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of plasma NT-proBNP for diagnosing heart failure in patients with previous myocardial infarction].
    Wei BQ; Zhang J; Yang YJ; Lü R; Zhang YH; Zhou Q; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jan; 40(1):34-8. PubMed ID: 22490631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
    Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
    Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes.
    Ranjith N; Pegoraro RJ; Naidoo DP; Esterhuizen TM
    Cardiovasc J S Afr; 2006; 17(2):60-6. PubMed ID: 16733598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
    Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
    J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.
    Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Flyvbjerg A; Faber J
    Metabolism; 2014 Jan; 63(1):141-9. PubMed ID: 24140097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
    Racek J; Králová H; Trefil L; Rajdl D; Eiselt J
    Nephron Clin Pract; 2006; 103(4):c162-72. PubMed ID: 16645318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.